Mr. Jeremy Yee
Non-Executive Non-Independent Chairman
From 1994 to 1995, Mr. Jeremy Yee was a corporate marketing officer (credit) at Maybank Finance (S) Limited in which he was responsible for the assessment of credit lending. From 1995 to 1996, he held the position of cadet/trainee pilot at Singapore Airlines Limited. From 1996 to 1997, he was a treasury analyst at American Express International Inc where he conducted foreign exchange hedging. From 1997 to 1999, he was a senior banking consultant at KPMG Consulting and was responsible for providing banking and treasury advisory services to the firm’s portfolio of clients. From 1999 to 2000, he was a risk management internal auditor at United Overseas Bank Limited where he provided risk management and audit services. From 2000 to 2002, he was an assistant managing consultant at KPMG Consulting and provided business consultancy services and led the management of the team.
From 2002 to 2011, he was director of corporate development, and then chief operating officer and subsequently executive director and group chief financial officer of Cordlife Limited (now known as Life Corporation Limited), a company listed on the Australian Securities Exchange. During his tenure, he was responsible for the group’s overall corporate development activities, financial function, including statutory filings, accounting audits, finance controls and treasury matters. From 2011 to 2016, he was appointed as executive director and chief executive officer of Cordlife Group Limited, a company listed on SGX-ST.
Mr. Jeremy Yee founded Clearbridge Medical Group Pte. Ltd. (formerly known as Insight Medica Pte. Ltd.) in 2016. Since 2017, Mr. Jeremy has served as the executive director and chief executive officer of Clearbridge Health, a company listed on SGX-ST, where he is responsible for identifying and implementing company-wide business growth strategies and overseeing all aspects of the group’s growth and operating functions.
Mr. Jeremy Yee obtained his Bachelor of Arts in Economic and Social Studies from the Victoria University of Manchester in 1994, Master of Commerce (Finance with Banking/Management) from the University of Sydney in 1997, Bachelor of Commerce in Professional Accounting from Murdoch University in 2009, Master of Business Administration from Nanyang Technological University in 2011, Master of Business Administration from the University of Chicago Booth School of Business in 2012 and Master of Arts from Columbia University in 2016. He completed the UC Berkeley – Nanyang Advanced Management Program in 2010. He also received the Furama Ltd Endowed Book Prize from Nanyang Technological University in 2011.
Mr. Ivan Lew
Executive Director and CEO
As Executive Director and CEO of Biolidics, Mr. Ivan Lew is responsible for the overall management of our Company.
From 1997 to 2000, Mr. Ivan Lew was the business development manager of Novahealth Pte Ltd, a provider of software solutions to healthcare institutions. From 2000 to 2002, he was director at Inventis Singapore Pte Ltd, where he led the marketing team. From 2002 to 2005, he was a senior vice president at Stratech Systems Limited, a surveillance technology provider, where he led the sales and project team. From 2005 to 2008, he was vice president of group business development and head of performance and strategy at Sembcorp Industries Ltd, an energy, water, marine and urban development group, where he was responsible for business development and operations. From 2008 to 2011, he returned to Stratech Systems Limited, where he served as a senior vice president.
From 2011 to 2014, he served as the chief executive officer and director of business development at Ramky International (Singapore) Pte. Ltd., an environmental management solution provider, where he led various business development initiatives and partnerships. From 2015 to 2016, he served as the chief executive officer of C&G (Asia) Engineering Pte Ltd, a company in the engineering, procurement and construction industry, where he managed the Singapore operations.
From 2016 to 2018, Mr. Ivan Lew was the chief executive officer of Shaw Investment APAC Pte. Ltd., an investment company, where he managed the Singapore and regional operations and was responsible for executing business growth strategies.
Mr. Ivan Lew graduated with a Bachelor of Science in Naval Architecture from the Western Australia Institute of Technology in 1988. He also obtained a Diploma in Shipbuilding and Offshore Engineering from Ngee Ann Polytechnic in 1990.
Mr. Johnson Chen
Non-Executive Non-Independent Director and Founder
From 1997 to 1998, Mr. Johnson Chen was an analyst with Anderson Consulting Strategic Services (now known as Accenture LLP) where he provided management consultancy services to clients and his primary responsibilities included industry research, analysis, business modelling and strategic planning. From 1998 to 1999, he was the deputy chief financial officer of Hong Kong Star Internet, where he was responsible for managing finance operations, budgets and project finance matters.
From 1999 to 2002, he was president of CyberWorks Ventures, the venture capital arm of Pacific Century CyberWorks in Hong Kong, where he oversaw CyberWorks Ventures’ direct investment and venture capital team. Since 2002, he has been an executive director of 1Bridge Partners Limited, where he oversees its investment management. Concurrently, he is the chairman, executive director and chief executive officer of CapBridge Pte. Ltd. (a global private financing platform and an entity regulated by the Authority) since 2017, where he is responsible for the overall strategic planning and business execution of the company. Mr. Johnson Chen also currently serves as the non-executive non-independent chairman of Clearbridge Health, a company listed on SGX-ST, a position he has held since 2017.
Mr. Johnson Chen graduated with a Bachelor of Arts degree and a Master of Engineering degree from the University of Cambridge, the UK in 1997.